(Q34993474)

5 August 2017

Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells (English)

1 reference

5 August 2017

0 references

S Cerrato

1

1 reference

5 August 2017

P Brazis

2

1 reference

5 August 2017

M F della Valle

3

1 reference

5 August 2017

A Miolo

4

1 reference

5 August 2017

A Puigdemont

5

1 reference

5 August 2017

27 June 2009

1 reference

Veterinary Immunology and Immunopathology

5 August 2017

1 reference

5 August 2017

133

1 reference

5 August 2017

1

1 reference

5 August 2017

9-15

1 reference

A proposed autacoid mechanism controlling mastocyte behaviour

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Evaluation of cell-surface IgE receptors on the canine mastocytoma cell line C2 maintained in continuous culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Stem cell factor enhances IgE-mediated histamine and TNF-alpha release from dispersed canine cutaneous mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Acute Intracerebroventricular Administration of Palmitoylethanolamide, an Endogenous Peroxisome Proliferator-Activated Receptor- Agonist, Modulates Carrageenan-Induced Paw Edema in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

The role of mast cells in atopy: what can we learn from canine models? A thorough review of the biology of mast cells in canine and human systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

The Paul Kallos Memorial Lecture. The mast cell: a versatile effector cell for a challenging world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Effects of the cannabimimetic fatty acid derivatives 2-arachidonoylglycerol, anandamide, palmitoylethanolamide and methanandamide upon IgE-dependent antigen-induced beta-hexosaminidase, serotonin and TNF alpha release from rat RBL-2H3 basophilic leu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Influence of vitamin E on mast cell mediator release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Skin mast cell histamine release following stem cell factor and high-affinity immunoglobulin E receptor cross-linking in dogs with atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

The palmitoylethanolamide family: a new class of anti-inflammatory agents?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Nuclear receptors as targets for drug development: peroxisome proliferator-activated receptor gamma in mast cells: its roles in proliferation and differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Mast cells enhance T cell activation: Importance of mast cell-derived TNF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

The orphan receptor GPR55 is a novel cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Differential roles of CB1 and CB2 cannabinoid receptors in mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Regulation of nerve growth factor induced histamine and arachidonic acid release from rat mast cells by cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Mast cell-associated TNF promotes dendritic cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Flea bite hypersensitivity: new aspects on the involvement of mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1alpha /beta released from neutrophils recruited by mast cell-derived TNFalpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Evaluation of fatty acid amides in the carrageenan-induced paw edema model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Immune dysregulation in flea allergy dermatitis--a model for the immunopathogenesis of allergic dermatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.06.011

10.1016/J.VETIMM.2009.06.011

7 January 2021

Identifiers

DOI

1 reference

5 August 2017

1 reference